Bastion Health

Bastion provides annual PSA screening along USPTF guidelines for Mens Health. Our FDA and CLIA approved tests provide easy, confidential access at 50% reduced cost to in network alternatives. Men enjoy at-home access, privacy and simplicity increasing preventative care and accelerating diagnosis to lower cost of care. Actuarial analysis indicates the cost of care variation for Stage 1 vs. Stage 3/4 diagnosis is between $89K and $309K to the plan; which helps define Bastion's financial and clinical impact to the member and plan. For patients with acuity, Bastion escalates and refers these members at the "Point of Need" to your In Network providers - oncologist via our Athena EMR frame to efficiently and effectively navigate to evidence based cancer support.